FGI Surges 98% After 500% EPS Growth Projection Signals Turnaround
FGI Industries led today's movers with a 97.7% surge from $3.85 to $7.61 after our screener detected a 500% EPS growth projection for next year—a signal that the market had dramatically mispriced the consumer cyclical name. AESI followed with a 29.1% gain after its EPS estimate jumped 26.9 percentage points to 165.4% growth, while LEGN and CRDO each climbed ~39% on smaller revisions that nonetheless signaled strong earnings momentum.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| FGI | Consumer Cyclical | 2026-04-13 | N/A | +97.7% |
| CRDO | Technology | 2026-04-13 | +0.8pp | +39.4% |
| LEGN | Healthcare | 2026-04-14 | +0.4pp | +39.2% |
| AESI | Energy | 2026-04-13 | +26.9pp | +29.1% |
| BEEM | Technology | 2026-04-14 | N/A | +26.0% |
FGI — FGI Industries Ltd
FGI Industries exploded 97.7% from $3.85 to $7.61 in nine trading days after our screener flagged a 500% EPS growth projection for next year—a signal that analysts anticipated either a dramatic margin recovery or a fundamental shift in the company's profitability trajectory. The consumer cyclical name had traded near multi-year lows, meaning the EPS revision represented a potential inflection point from deep losses toward profitability that the market had failed to price in. With no recent news to attribute the move to, the surge reflects a pure earnings expectation re-rating: when a low-priced stock carries a 500% growth projection, even modest absolute earnings improvements translate into outsized percentage gains that attract momentum buyers. The doubling of the share price suggests short covering may have amplified the move once the technical breakout above $4.50 occurred.
View screener snapshot from 2026-04-13 →CRDO — Credo Technology Group Holding Ltd
Credo Technology climbed 39.4% from $134.36 to $187.26 after a modest 0.8 percentage point EPS revision to 43.2% growth triggered significant buying in this semiconductor-related name. The relatively small upward adjustment (42.5% to 43.2%) produced a outsized price response because Credo sits at the intersection of two powerful market narratives: AI infrastructure buildout and high-speed connectivity solutions for data centers. At $134 when detected, the stock had not yet fully reflected consensus optimism around hyperscaler spending, and the EPS confirmation acted as validation that demand visibility was strengthening. The stock breaking through $170 resistance accelerated buying from trend-following algorithms, creating a self-reinforcing move that outpaced the fundamental revision magnitude.
View screener snapshot from 2026-04-13 →LEGN — Legend Biotech Corp ADR
Legend Biotech surged 39.2% from $18.69 to $26.02 after a marginal 0.4 percentage point EPS revision to 312.3% growth—the tiny upward adjustment belied a massive price response that points to binary event pricing in the shares. The 312% projected EPS growth implies analysts expect Legend's CAR-T cell therapy pipeline to generate substantial revenue or successful partnership milestones that dramatically improve profitability. At sub-$20 prices, the market was pricing in significant clinical or regulatory risk, and any confirmation of the earnings trajectory signals that risk is decreasing. Healthcare biopharma names with high growth projections frequently exhibit this disconnect between small EPS revisions and large price moves because investors are positioning for catalysts rather than current quarter results.
View screener snapshot from 2026-04-14 →AESI — Atlas Energy Solutions Inc
Atlas Energy Solutions gained 29.1% from $11.71 to $15.12 after the largest absolute EPS revision on our list—a 26.9 percentage point jump to 165.4% growth that reflected significantly improved commodity price assumptions or volume expectations. The energy services name benefits from increased Permian Basin activity, and the EPS revision suggests Atlas is capturing both higher sand volumes and improved pricing power as E&P operators increase drilling budgets. At $11.71 when detected, the stock traded at a discount to intrinsic value that the revised earnings power quickly corrected. The 29% gain in nine days indicates the market reassessed Atlas's forward earnings multiple in line with higher energy sector valuations generally.
View screener snapshot from 2026-04-13 →BEEM — Beam Global
Beam Global rallied 26.0% from $1.50 to $1.89 after our screener detected a 78% EPS growth projection for next year, propelling the micro-cap EV charging infrastructure name to its highest level in months. The 78% growth estimate represents a meaningful improvement in profitability expectations for a company that had struggled with slow municipal adoption of its beam-mounted EV charging systems. At $1.50, the stock had been priced for distress, meaning any signal that earnings trajectory was improving attracted speculative buying. The move to $1.89 brings the stock back toward more normalized valuation territory, though remaining a sub-$2 name suggests the market still demands further proof of execution before assigning a higher multiple.
View screener snapshot from 2026-04-14 →Today's movers reveal a market willing to assign dramatic valuations to names with high EPS growth projections, particularly when those projections represent turnarounds (FGI) or binary opportunities (LEGN). The disconnect between modest EPS revisions and massive price gains in CRDO and LEGN signals that investors are pricing future catalysts rather than current fundamentals, while AESI's 26.9pp revision shows that real earnings momentum in energy services commands immediate multiple expansion.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →